Author | Stuart Lutzker, MD, PhD | OncLive

Author | Stuart Lutzker, MD, PhD

Articles

Dr. Lutzker on OX40 Agonist in Patients With Refractory Solid Tumors

May 23, 2016

Video

Stuart Lutzker, MD, PhD, vice president of BioOncology Exploratory Clinical Development, Genentech, discusses results of the first-in-human study of OX40 agonist in patients with refractory solid tumors.

x